121 related articles for article (PubMed ID: 21736709)
21. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.
Tang K; Ngoi SM; Gwee PC; Chua JM; Lee EJ; Chong SS; Lee CG
Pharmacogenetics; 2002 Aug; 12(6):437-50. PubMed ID: 12172212
[TBL] [Abstract][Full Text] [Related]
22. Human Vav1 expression in hematopoietic and cancer cell lines is regulated by c-Myb and by CpG methylation.
Ilan L; Katzav S
PLoS One; 2012; 7(1):e29939. PubMed ID: 22253833
[TBL] [Abstract][Full Text] [Related]
23. A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression.
Sun J; Lei Z; Liu RY; Lu Y; Zhuang Z; Jiang X; Qian Q; Liu Z; Zhao J; Zhang HT
Oncol Rep; 2011 Mar; 25(3):685-91. PubMed ID: 21225232
[TBL] [Abstract][Full Text] [Related]
24. Enhancer element potentially involved in human survivin gene promoter regulation in lung cancer cell lines.
Mityaev MV; Kopantzev EP; Buzdin AA; Vinogradova TV; Sverdlov ED
Biochemistry (Mosc); 2010 Feb; 75(2):182-91. PubMed ID: 20367605
[TBL] [Abstract][Full Text] [Related]
25. Linkage disequilibrium pattern in the L-myc gene in Italian and Japanese non-small-cell lung-cancer patients.
Spinola M; Nomoto T; Manenti G; Falvella FS; Brega Massone PP; Conti B; Cataldo I; Valagussa P; Incarbone M; Miyamoto K; Ushijima T; Dragani TA
Int J Cancer; 2001 Sep; 95(5):329-31. PubMed ID: 11494234
[TBL] [Abstract][Full Text] [Related]
26. A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk.
Chen J; Liu RY; Yang L; Zhao J; Zhao X; Lu D; Yi N; Han B; Chen XF; Zhang K; He J; Lei Z; Zhou Y; Pasche B; Li X; Zhang HT
J Cancer Res Clin Oncol; 2013 Feb; 139(2):231-42. PubMed ID: 23052692
[TBL] [Abstract][Full Text] [Related]
27. Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer.
Wang T; Chen YH; Hong H; Zeng Y; Zhang J; Lu JP; Jeansonne B; Lu Q
Oncogene; 2009 Jan; 28(4):555-64. PubMed ID: 18978817
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
Nomura M; Shigematsu H; Li L; Suzuki M; Takahashi T; Estess P; Siegelman M; Feng Z; Kato H; Marchetti A; Shay JW; Spitz MR; Wistuba II; Minna JD; Gazdar AF
PLoS Med; 2007 Apr; 4(4):e125. PubMed ID: 17455987
[TBL] [Abstract][Full Text] [Related]
29. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
Riemann K; Struwe H; Eisenhardt A; Obermaier B; Schmid KW; Siffert W
Pharmacogenet Genomics; 2008 Nov; 18(11):999-1008. PubMed ID: 18815590
[TBL] [Abstract][Full Text] [Related]
30. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the 5'-untranslated region of the human serotonin receptor 1B (HTR1B) gene affect gene expression.
Duan J; Sanders AR; Molen JE; Martinolich L; Mowry BJ; Levinson DF; Crowe RR; Silverman JM; Gejman PV
Mol Psychiatry; 2003 Nov; 8(11):901-10. PubMed ID: 14593427
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific, hypoxia-regulated, WW domain-containing oxidoreductase-expressing adenovirus inhibits human non-small cell lung cancer growth in vivo.
Zhang P; Ying L; Xu R; Ge S; Mei W; Li F; Dai B; Lu J; Qian G
Hum Gene Ther; 2010 Jan; 21(1):27-39. PubMed ID: 19737107
[TBL] [Abstract][Full Text] [Related]
33. WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC).
Baykara O; Demirkaya A; Kaynak K; Tanju S; Toker A; Buyru N
Tumour Biol; 2010 Aug; 31(4):315-20. PubMed ID: 20480411
[TBL] [Abstract][Full Text] [Related]
34. Differential promoter activity by nucleotide substitution at a type 2 diabetes genome-wide association study signal upstream of the wolframin gene.
Ryu J; Lee C
J Diabetes; 2016 Mar; 8(2):253-9. PubMed ID: 25800097
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.
Wu C; Xu B; Yuan P; Miao X; Liu Y; Guan Y; Yu D; Xu J; Zhang T; Shen H; Wu T; Lin D
Cancer Res; 2010 Dec; 70(23):9721-9. PubMed ID: 21118971
[TBL] [Abstract][Full Text] [Related]
36. Non-association of VEGF genetic polymorphisms in promoter--5' UTR with end-stage renal disease.
Doi K; Noiri E; Fujita T; Tokunaga K
Nephrol Dial Transplant; 2006 Apr; 21(4):1124-5; author reply 1125. PubMed ID: 16421153
[No Abstract] [Full Text] [Related]
37. MICB gene diversity and balancing selection on its promoter region in Yao population in southern China.
Chen X; Liu X; Wei X; Meng Y; Liu L; Qin S; Liu Y; Dai S
Hum Immunol; 2016 Dec; 77(12):1187-1193. PubMed ID: 27591811
[TBL] [Abstract][Full Text] [Related]
38. Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer.
Lind H; Zienolddiny S; Ekstrøm PO; Skaug V; Haugen A
Int J Cancer; 2006 Aug; 119(3):718-21. PubMed ID: 16496380
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
Lahiri DK; Ge YW; Maloney B
FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
[TBL] [Abstract][Full Text] [Related]
40. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
